The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?
Open accessAbstract
Angiogenesis has been regarded as essential for tumor growth and progression. Studies of many human tumors, however, suggest that their microcirculation may be provided by nonsprouting vessels and that a variety of tumors can grow and metastasize without angiogenesis. Vessel co‐option, where tumor cells migrate along the preexisting vessels of the host organ, is regarded as an alternative tumor blood supply. Vessel co‐option may occur in many malignancies, but so far mostly reported in highly vascularized tissues such as brain, lung, and liver. In primary and metastatic lung cancer and liver metastasis from different primary origins, as much as 10–30% of the tumors are reported to use this alternative blood supply. In addition, vessel co‐option is introduced as a potential explanation of antiangiogenic drug resistance, although the impact of vessel co‐option in this clinical setting is still to be further explored. In this review we discuss tumor vessel co‐option with specific examples of vessel co‐option in primary and secondary tumors and a consideration of the clinical implications of this alternative tumor blood supply.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Real-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Lu, K. V., Chang, J. P., Parachoniak, C. A., Pandika, M. M., Aghi, M. K., Meyronet, D., Isachenko, N., Fouse, S. D., Phillips, J. J., Cheresh, D. A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.037 · Cited by 550
Rubenstein, J. L., Kim, J., Ozawa, T., Zhang, M., Westphal, M., Deen, D. F., & Shuman, M. A. (2000) · Neoplasia · doi:10.1038/sj.neo.7900102 · Cited by 509
Hu, Y.-L., DeLay, M., Jahangiri, A., Molinaro, A. M., Rose, S. D., Carbonell, W. S., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3831 · Cited by 483
Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma
Auf, G., Jabouille, A., Guérit, S., Pineau, R., Delugin, M., Bouchecareilh, M., Magnin, N., Favereaux, A., Maitre, M., Gaiser, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914072107 · Cited by 331
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.
Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S. A., Sozzi, G., Gasparini, G. M., Menard, S., Gatter, K. C., Harris, A. L., Fox, S. B., et al. (1997) · Europe PMC (PubMed Central) · Cited by 330
Self-citationThe Vascular Basement Membrane as “Soil” in Brain Metastasis
Carbonell, W. S., Ansorge, O., Sibson, N., & Muschel, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005857 · Cited by 329
Vermeulen, P. B., Colpaert, C., Salgado, R., Royers, R., Hellemans, H., Van den Heuvel, E., Goovaerts, G., Dirix, L. Y., & Van Marck, E. (2001) · The Journal of Pathology · doi:10.1002/path.966 · Cited by 312
Leenders, W. P. J., Küsters, B., Verrijp, K., Maass, C., Wesseling, P., Heerschap, A., Ruiter, D., Ryan, A., & de Waal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0823 · Cited by 231
Vajkoczy, P., Farhadi, M. R., Gaumann, A. K. A., Heidenreich, R., Erber, R., Wunder, A., Tonn, J. C., Menger, M. D., & Breier, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14105 · Cited by 219
Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
Self-citationWinkler, F., Kienast, Y., Fuhrmann, M., Von Baumgarten, L., Burgold, S., Mitteregger, G., Kretzschmar, H., & Herms, J. (2009) · Glia · doi:10.1002/glia.20850 · Cited by 210
Allegra, C. J., Yothers, G., O'Connell, M. J., Sharif, S., Petrelli, N. J., Lopa, S. H., & Wolmark, N. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.4711 · Cited by 209
di Tomaso, E., Snuderl, M., Kamoun, W. S., Duda, D. G., Auluck, P. K., Fazlollahi, L., Andronesi, O. C., Frosch, M. P., Wen, P. Y., Plotkin, S. R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2602 · Cited by 199
Signalling pathways in vasculogenic mimicry
Paulis, Y. W. J., Soetekouw, P. M. M. B., Verheul, H. M. W., Tjan-Heijnen, V. C. G., & Griffioen, A. W. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.001 · Cited by 188
Renyi-Vamos, F., Tovari, J., Fillinger, J., Timar, J., Paku, S., Kenessey, I., Ostoros, G., Agocs, L., Soltesz, I., & Dome, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1077 · Cited by 181
Helfrich, I., Scheffrahn, I., Bartling, S., Weis, J., von Felbert, V., Middleton, M., Kato, M., Ergün, S., Augustin, H. G., & Schadendorf, D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091846 · Cited by 170
Helfrich, I., Scheffrahn, I., Bartling, S., Weis, J., von Felbert, V., Middleton, M., Kato, M., Ergün, S., Augustin, H. G., & Schadendorf, D. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.200918462104c · Cited by 163
Küsters, B., Leenders, W. P. J., Wesseling, P., Smits, D., Verrijp, K. C. N., Ruiter, D. J., Peters, J. P. W., van der Kogel, A. J., & de Waal, R. M. W. (2002) · PubMed · Cited by 152
Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib
Welti, J. C., Gourlaouen, M., Powles, T. B., Kudahetti, S. C., Wilson, P. A., Berney, D. M., & Reynolds, A. R. (2010) · Oncogene · doi:10.1038/onc.2010.503 · Cited by 135
The histological growth pattern of colorectal cancer liver metastases has prognostic value
den Eynden, G. G. V., Bird, N. C., Majeed, A. W., Laere, S. V., Dirix, L. Y., & Vermeulen, P. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9469-1 · Cited by 128
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
Passalidou, E., Trivella, M., Singh, N., Ferguson, M. L., Hu, J., Cesario, A., Granone, P. L., Nicholson, A. G., Goldstraw, P. G., Ratcliffe, C., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600015 · Cited by 125
Self-citationde Oliveira, R. L., Hamm, A., & Mazzone, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.001 · Cited by 116
Wesseling, P., van der Laak, J. A. W. M., de Leeuw, H., Ruiter, D. J., & Burger, P. C. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.81.6.0902 · Cited by 113
Targeting the Angiopoietin/Tie2 Pathway: Cutting Tumor Vessels With a Double-Edged Sword?
Cascone, T., & Heymach, J. V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.7621 · Cited by 108
Angiogenesis in primary lung cancer and lung secondaries
Pezzella, F., Bacco, A. D., Andreola, S. A., et al. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00377-2 · Cited by 100
Self-citationGene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer
Hu, J., Bianchi, F., Ferguson, M. L., Cesario, A., Margaritora, S., Granone, P. M., Goldstraw, P. G., Tetlow, M., Ratcliffe, C., Nicholson, A. G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208242 · Cited by 87
Self-citationTumor-Surrogate Blood Vessel Subtypes Exhibit Differential Susceptibility to Anti-VEGF Therapy
Sitohy, B., Nagy, J. A., Jaminet, S.-C. S., & Dvorak, H. F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1693 · Cited by 82
Angiogenesis is redundant for tumour growth in lymph node metastases
Naresh, K. N., Nerurkar, A. Y., & Borges, A. M. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01061.x · Cited by 79
Leenders, W. P. J., Küsters, B., Pikkemaat, J. A., Wesseling, P., Ruiter, D. J., Heerschap, A., Barentsz, J. O., & de Waal, R. M. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11102 · Cited by 71
Zhao, C., Yang, H., Shi, H., Wang, X., Chen, X., Yuan, Y., Lin, S., & Wei, Y. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr076 · Cited by 70
Contrasting effects of sunitinib within in vivo models of metastasis
Welti, J. C., Powles, T. B., Foo, S., Gourlaouen, M., Preece, N., Foster, J., Frentzas, S., Bird, D., Sharpe, K., van Weverwijk, A., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9291-z · Cited by 69
To sprout or to split? VEGF, Notch and vascular morphogenesis
Giannì-Barrera, R., Trani, M., Reginato, S., & Banfi, A. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110650 · Cited by 64
Shieh, Y., Lee, H., Shiah, S., Chu, Y., Wu, C., & Chang, L. (2004) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2004.00252.x · Cited by 60
Targeted therapies of cancer: Angiogenesis inhibition seems not enough
Roodink, I., & Leenders, W. P. J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.004 · Cited by 57
Offersen, B. V., Pfeiffer, P., Andreasen, P. A., & Overgaard, J. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.018 · Cited by 55
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin‐2
Reiss, Y., Knedla, A., Tal, A. O., Schmidt, M. H. H., Jugold, M., Kiessling, F. M., Burger, A. M., Wolburg, H., Deutsch, U., & Plate, K. H. (2008) · The Journal of Pathology · doi:10.1002/path.2484 · Cited by 53
Yousem, S. A. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.11.008 · Cited by 47
Mehta, S., Hughes, N. P., Buffa, F. M., Li, S., Adams, R. F., Adwani, A., Taylor, N. J., Levitt, N. C., Padhani, A. R., Makris, A., et al. (2011) · JNCI Monographs · doi:10.1093/jncimonographs/lgr027 · Cited by 43
Self-citationDistinct angiogenic and non‐angiogenic growth patterns of lung metastases from renal cell carcinoma
Nia, P. S., Hendriks, J. M., Friedel, G., Schil, P. E. V., & Marck, E. V. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02800.x · Cited by 41
Different Growth Patterns of Non-Small Cell Lung Cancer Represent Distinct Biologic Subtypes
Nia, P. S., Colpaert, C., Vermeulen, P., et al. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.08.054 · Cited by 40
Adjuvant Therapy in Non–Small Cell Lung Cancer: Future Treatment Prospects and Paradigms
Carbone, D. P., & Felip, E. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.06.002 · Cited by 36
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma
Kaicker, S. M., McCrudden, K. W., Beck, L., New, T. N., Huang, J., Frischer, J. S., Serur, A., Kadenhe‐Chiweshe, A. V., Yokoi, A., Kandel, J. J., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.6.1651 · Cited by 36
Paku, S., Kopper, L., & Nagy, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.20886 · Cited by 35
Arismendi-Morillo, G., & Castellano, A. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-5674-3 · Cited by 33
Budde, M. D., Gold, E. M., Jordan, E. K., & Frank, J. A. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9428-2 · Cited by 30
Adighibe, O., Micklem, K., Campo, L., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603039 · Cited by 26
Self-citationPhase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain
Budde, M. D., Gold, E. M., Jordan, E. K., Smith‐Brown, M., & Frank, J. A. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1786 · Cited by 21
Why do targeted agents not work in the adjuvant setting in colon cancer?
Oyan, B. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.111 · Cited by 12
Cited by
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363
The Acidic Tumor Microenvironment as a Driver of Cancer
Boedtkjer, E., & Pedersen, S. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034627 · Cited by 1,223
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Valiente, M., Obenauf, A. C., Jin, X., Chen, Q., Zhang, X. H.-F., Lee, D. J., Chaft, J. E., Kris, M. G., Huse, J. T., Brogi, E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.040 · Cited by 877
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Vasudev, N. S., & Reynolds, A. R. (2014) · Angiogenesis · doi:10.1007/s10456-014-9420-y · Cited by 738
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Zhu, Y.-J., Zheng, B., Wang, H.-Y., & Chen, L. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.5 · Cited by 702
Metadata
- Authors
- Donnem, T., Hu, J., Ferguson, M., Adighibe, O., Snell, C., Harris, A. L., Gatter, K. C., & Pezzella, F.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2013-07-08
- Volume
- 2
- Issue
- 4
- Pages
- 427-436
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2170633837
- Cited by
- 275
- References
- 53
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.